Literature DB >> 29193372

Summary of the UAA-AAUS guidelines for urinary tract infections.

Hyun-Sop Choe1, Seung-Ju Lee1, Stephen S Yang2, Ryoichi Hamasuna3, Shingo Yamamoto4, Yong-Hyun Cho5, Tetsuro Matsumoto3.   

Abstract

Urinary tract infections, genital tract infections and sexually transmitted infections are the most prevalent infectious diseases, and the establishment of locally optimized guidelines is critical to provide appropriate treatment. The Urological Association of Asia has planned to develop the Asian guidelines for all urological fields, and the present urinary tract infections, genital tract infections and sexually transmitted infections guideline was the second project of the Urological Association of Asia guideline development, which was carried out by the Asian Association of Urinary Tract Infection and Sexually Transmitted Infection. The members have meticulously reviewed relevant references, retrieved via the PubMed and MEDLINE databases, published between 2009 through 2015. The information identified through the literature review of other resources was supplemented by the author. Levels of evidence and grades of recommendation for each management were made according to the relevant strategy. If the judgment was made on the basis of insufficient or inadequate evidence, the grade of recommendation was determined on the basis of committee discussions and resultant consensus statements. Here, we present a short English version of the original guideline, and overview its key clinical issues.
© 2017 The Japanese Urological Association.

Entities:  

Keywords:  guideline; sexually transmitted infection; urinary tract infection

Mesh:

Year:  2017        PMID: 29193372     DOI: 10.1111/iju.13493

Source DB:  PubMed          Journal:  Int J Urol        ISSN: 0919-8172            Impact factor:   3.369


  8 in total

1.  [Infection management in TURP shows need for improvement despite evidence-based guideline recommendations : Results from the Global Prevalence Study of Infections in Urology].

Authors:  J Kranz
Journal:  Urologe A       Date:  2019-11       Impact factor: 0.639

2.  Systematic review: bacterial colonisation of conduits and neobladders-when to test, watch, and treat.

Authors:  Liang G Qu; Ahmed Adam; Weranja Ranasinghe; Nathan Lawrentschuk
Journal:  World J Urol       Date:  2019-09-27       Impact factor: 4.226

3.  The effect of fluoroquinolones and antioxidans on biofilm formation by Proteus mirabilis strains.

Authors:  Jana Przekwas; Jakub Gębalski; Joanna Kwiecińska-Piróg; Natalia Wiktorczyk-Kapischke; Ewa Wałecka-Zacharska; Eugenia Gospodarek-Komkowska; Dorota Rutkowska; Krzysztof Skowron
Journal:  Ann Clin Microbiol Antimicrob       Date:  2022-06-02       Impact factor: 6.781

4.  Risk factors for urinary infection after retrograde upper urinary lithotripsy: Implication for nursing.

Authors:  Chuan Peng; Zhaozhao Chen; Jun Xu
Journal:  Medicine (Baltimore)       Date:  2021-08-06       Impact factor: 1.817

Review 5.  Recurrent Urinary Tract Infections and Asymptomatic Bacteriuria in Adults.

Authors:  David Hernández-Hernández; Bárbara Padilla-Fernández; María Yanira Ortega-González; David Manuel Castro-Díaz
Journal:  Curr Bladder Dysfunct Rep       Date:  2021-12-01

6.  Influence of beta-blocker therapy on the risk of infections and death in patients at high risk for stroke induced immunodepression.

Authors:  Ilko L Maier; Johannes C Becker; Johanna Rosemarie Leyhe; Marlena Schnieder; Daniel Behme; Marios-Nikos Psychogios; Jan Liman
Journal:  PLoS One       Date:  2018-04-25       Impact factor: 3.240

7.  Urolithiasis Is a Risk Factor for Uroseptic Shock and Acute Kidney Injury in Patients With Urinary Tract Infection.

Authors:  Chih-Yen Hsiao; Tsung-Hsien Chen; Yi-Chien Lee; Meng-Chang Hsiao; Peir-Haur Hung; Yih-Yuan Chen; Ming-Cheng Wang
Journal:  Front Med (Lausanne)       Date:  2019-12-05

8.  High Prevalence of Extended-Spectrum Beta-Lactamases in Escherichia coli Strains Collected From Strictly Defined Community-Acquired Urinary Tract Infections in Adults in China: A Multicenter Prospective Clinical Microbiological and Molecular Study.

Authors:  Peiyao Jia; Ying Zhu; Xue Li; Timothy Kudinha; Yang Yang; Ge Zhang; Jingjia Zhang; Yingchun Xu; Qiwen Yang
Journal:  Front Microbiol       Date:  2021-07-07       Impact factor: 5.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.